Bionano Genomics announced a publication outlining the addition of optical genome mapping, OGM, to the International System for Human Cytogenomic Nomenclature, ISCN. The OGM nomenclature is expected to be published in the 2024 edition of the ISCN guide, a reference volume covering ISCN nomenclature that is utilized worldwide by cytogeneticists, molecular biologists, technicians, and students. “We are pleased to see the ISCN committee recognize OGM through its inclusion in their nomenclature, which has been a standard reference for cytogeneticists since 1960. An international nomenclature is essential for clear communication in publications and consistency in databases. This nomenclature will serve as a practical and easily available reference that will enable genetic laboratories to maintain consistent levels of reporting on OGM findings. Inclusion in ISCN is a significant milestone for OGM and for researchers using the workflow to advance molecular cytogenetics,” added Erik Holmlin, PhD, president and chief executive officer of Bionano.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BNGO:
- International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications
- Bionano Genomics upgrades optical genome mapping pipeline
- Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA™ Software for OGM Data Analysis in Constitutional Genetic Disease Research
- Bionano Genomics announces publication comparing OGM to CMA and KT
- Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping